European Autism GEnomics Registry (EAGER): protocol for a multicentre cohort study and registry.
Madeleine BloomfieldBianca Alexandra LautarescuSíofra HeratySarah DouglasPierre ViollandRoderik PlasAnjuli GhoshKatrien Van den BoschEliza EatonMichael AbsoudRoberta BattiniAna Blázquez HinojosaNadia BolshakovaSven BöltePaolo BonanniJacqueline BorgSara CalderoniRosa Calvo EscalonaMiguel Castelo-BrancoJosefina Castro-FornielesPilar CaroFreddy CliquetAlberto DanieliRichard DelormeMaurizio EliaMaja HempelClaire S LeblondNuno MadeiraGrainne McAlonanRoberta MiloneCiara J MolloySusana MougaVirginia MontielAna Pina RodriguesChristian P SchaafMercedes SerranoKristiina TammimiesCharlotte TyeFederico VigevanoGuiomar OliveiraBeatrice MazzoneCara O'NeillJulie PenderVerena RomeroJulian TillmannBethany OakleyDeclan G M MurphyLouise GallagherThomas BourgeronChristopher ChathamTony CharmanPublished in: BMJ open (2024)
To date, EAGER has received full ethical approval for 11 out of the 13 sites in the UK (REC 23/SC/0022), Germany (S-375/2023), Portugal (CE-085/2023), Spain (HCB/2023/0038, PIC-164-22), Sweden (Dnr 2023-06737-01), Ireland (230907) and Italy (CET_62/2023, CEL-IRCCS OASI/24-01-2024/EM01, EM 2024-13/1032 EAGER). Findings will be disseminated via scientific publications and conferences but also beyond to participants and the wider community (eg, the AIMS-2-TRIALS website, stakeholder meetings, newsletters).